FASN and cancer: Fatty acid synthase (FASN) upregulated by human epidermal growth factor receptor 2 (Erb-B2) (also known as HER/neu), a tyrosine kinase receptor, is frequently overexpressed in cancer cells, which promotes their invasiveness and proliferation (4).